Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2002
10/31/2002US20020161212 BPC-1: a secreted brain-specific protein expressed and secreted by prostate and bladder cancer cells
10/31/2002US20020161202 For modulating apoptosis in mammalian cells
10/31/2002US20020161201 For use in cancer diagnosis and therapy
10/31/2002US20020161196 Trail receptors nucleic acids encoding the same and methods of use thereof
10/31/2002US20020161195 Trail receptors, nucleic acids encoding the same, and methods of use thereof
10/31/2002US20020161191 Novel Imidazoline receptor homologs
10/31/2002US20020161178 Novel DKR polypeptides
10/31/2002US20020160977 Method for selective inactivation of viral replication
10/31/2002US20020160976 Method for selective inactivation of viral replication
10/31/2002US20020160503 Method for the separation of adsorbents from microbiological growth media
10/31/2002US20020160502 For use in immunotherapy
10/31/2002US20020160500 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203
10/31/2002US20020160499 For use in diagnosis, prophylaxis, and therapy of disorders associated with expression of serine carboxypeptidase
10/31/2002US20020160498 Can be used, for example, as target molecules for developing drugs against cancer
10/31/2002US20020160494 Tendon-inducing compositions
10/31/2002US20020160493 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
10/31/2002US20020160490 For screening physiologically active substances using serine protease or DNA that codes for it
10/31/2002US20020160489 Used in preparation of recombinant cells which produce hyaluronate synthase and its hyaluronic acid product
10/31/2002US20020160487 Testis specific transcription factor ZGCL-1
10/31/2002US20020160484 Central nervous system disorders therapy; genetic engineering
10/31/2002US20020160481 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof
10/31/2002US20020160477 CAF1-related protein
10/31/2002US20020160473 Far red shifted fluorescent proteins
10/31/2002US20020160468 Using nicotinamide-adenine dinucleotide coenzyme
10/31/2002US20020160461 Method for producing substance utilizing microorganism
10/31/2002US20020160451 Isolated nucleic acids; genetic engineering
10/31/2002US20020160448 Human c-Maf compositions and methods of use thereof
10/31/2002US20020160447 Ups (ugc)
10/31/2002US20020160444 Detect drug which alter film formation
10/31/2002US20020160408 Detection interaction between proteins
10/31/2002US20020160399 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
10/31/2002US20020160392 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/31/2002US20020160375 Generating tissue; cell differentiation
10/31/2002US20020160355 Methods and reagents for modulating TGF-beta superfamily signalling
10/31/2002US20020160079 Koji produced from soybean hypocotyl, preparation method thereof, and soy hypocotyl products prepared from said koji
10/31/2002US20020160022 Comprising viable wild type sporulated oocysts of protozoa known to cause coccidiosis, wherein composition is sterile and contains 10,000 oocysts per milliliter and less than 0.8% by weight of alkali metal permanganate
10/31/2002US20020160016 Modified surface antigen
10/31/2002US20020160015 Chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes and its uses
10/31/2002US20020159990 Synergistic degradation of oligosaccharides by endoglucanases, resulting in the production of ethanol from complex cellulose substrates
10/31/2002US20020159976 An isolated polynucleotide comprising a nucleotide sequence present in Lactobacillus rhamnosus strain HN001 that encodes a polypeptide having atleast one enzymetic activity; genetic engineering
10/31/2002US20020159884 Torsion generator
10/31/2002DE10120546A1 Verfahren zur Herstellung einer wässrigen Acrylamidlösung mit einem Biokatalysator A process for producing an aqueous acrylamide solution with a biocatalyst
10/31/2002DE10120061A1 Exopolysaccharidproduktion Exopolysaccharidproduktion
10/31/2002DE10119274A1 Enzymatisches Verfahren zur enantioselektiven Reduktion von Ketoverbindungen Enzymatic method for the enantioselective reduction of keto compounds
10/31/2002DE10118452A1 Nukleinsäuresequenzen von Hyperplasien und Tumoren der Schilddrüse Nucleic acid sequences of hyperplasias and tumors of the thyroid
10/31/2002CA2483507A1 Enzyme and snp marker for disease
10/31/2002CA2445354A1 Nucleic acid molecules encoding starch degrading enzymes
10/31/2002CA2445258A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides
10/31/2002CA2445255A1 Vhh single heavy chain antibody and a method for its preparation in a mammal
10/31/2002CA2445197A1 T1r3 a novel taste receptor
10/31/2002CA2445179A1 Identification of essential genes of aspegillus fumigatus and methods of use
10/31/2002CA2445168A1 Human timp-1 antibodies
10/31/2002CA2444819A1 Methods for generating libraries of therapeutic bacteriophages having desired safety characteristics and methods for labeling and monitoring bacteriophages
10/31/2002CA2444691A1 Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
10/31/2002CA2444683A1 Antimicrobial polypeptides and their uses
10/31/2002CA2444675A1 Secreted proteins
10/31/2002CA2444235A1 New polynucleotides and polypeptides of the ifn.alpha.-17 gene
10/31/2002CA2444195A1 Compositions and methods for recombinational cloning of nucleic acid molecules
10/31/2002CA2444098A1 Methods and compositions for the production of orthogonal trna-aminoacyl trna synthetase pairs
10/31/2002CA2443757A1 In vivo incorporation of unnatural amino acids
10/31/2002CA2443373A1 New polynucleotides and polypeptides of the erythropoietin gene
10/31/2002CA2441783A1 Genes involved in isoprenoid compound production
10/31/2002CA2441774A1 A product removal process for use in a biofermentation system
10/31/2002CA2439693A1 Nucleic acids of the human abcc12 gene, vectors containing such nucleic acids and uses thereof
10/31/2002CA2438833A1 Lactic acid bacteria as agents for treating and preventing allergy
10/31/2002CA2436216A1 Methods for identifying the target of a compound which inhibits cellular proliferation
10/31/2002CA2429351A1 A novel human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
10/30/2002EP1253475A2 Electrostatic charge image developing toner, producing method therefor, and image forming method and image forming apparatus utilizing the toner
10/30/2002EP1253202A1 Expression cassette comprising the Arabidopsis thaliana trehalose-6-phosphate synthase 3 (TPS3) promoter for strong constitutive gene expression
10/30/2002EP1253195A1 Process for producing l-lysine
10/30/2002EP1253160A2 Construct and method for making it
10/30/2002EP1252337A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252333A2 Methods and materials relating to cd84-like polypeptides and polynucleotides
10/30/2002EP1252328A2 Cell isolation method
10/30/2002EP1252324A1 Solventless extraction process
10/30/2002EP1252318A2 Allene oxide cyclase gene and use thereof for producing jasmonic acid
10/30/2002EP1252316A2 Gene cluster for everninomicin biosynthesis
10/30/2002EP1252313A2 Use of dendroaspin as a vehicle for non-dendroaspin domains
10/30/2002EP1252312A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252310A2 Mlp gene, nucleic acids, polypeptides and the utilization thereof
10/30/2002EP1252309A2 Mhc class ii restricted t cell epitopes from the cancer antigen ny-eso-1
10/30/2002EP1252306A1 Selective killing of cells by activation of double-stranded rna dependent protein kinase-pkr
10/30/2002EP1252305A2 Full-length human cdnas encoding potentially secreted proteins
10/30/2002EP1252303A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252302A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252301A1 Process and system for electrical extraction of intracellular matter from biological matter
10/30/2002EP1252300A2 Nucleic acid molecules encoding transmembrane serine proteases, the encoded proteins and methods based thereon
10/30/2002EP1252299A2 Aspartyl proteases
10/30/2002EP1252298A2 Phosphodiesterases
10/30/2002EP1252297A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252291A2 Flavobacterium heparinum expression system
10/30/2002EP1252290A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252289A2 Nucleic acids, proteins, and antibodies
10/30/2002EP1252189A2 Novel human nucleic acid molecules and polypeptides encoding cation channels
10/30/2002EP1252188A2 G-protein coupled receptors
10/30/2002EP1252187A2 Fil-1 theta dnas and polypeptides
10/30/2002EP1252185A1 Nucleic acids, proteins, and antibodies
10/30/2002EP1252182A1 PROTEINS COMPRISING CONSERVED REGIONS OF NEISSERIA MENINGITIDIS SURFACE ANTIGEN NhhA
10/30/2002EP1252180A2 Virulence genes, proteins, and their use
10/30/2002EP1252177A1 Ligand for vascular endothelial growth factor receptor
1 ... 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 ... 1489